Selected article for: "acute exacerbation and lung interstitial"
Author: Jang, Hye Jin; Yong, Seung Hyun; Leem, Ah Young; Lee, Su Hwan; Kim, Song Yee; Lee, Sang Hoon; Kim, Eun Young; Chung, Kyung Soo; Jung, Ji Ye; Kang, Young Ae; Kim, Young Sam; Chang, Joon; Park, Moo Suk
Title: Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
  • Cord-id: rff6zdmm
  • Document date: 2021_3_11
    • ID: rff6zdmm
    Snippet: Interstitial lung disease (ILD), particularly idiopathic pulmonary fibrosis (IPF), has a poor prognosis. Corticosteroids are widely used in the treatment of acute exacerbation of ILD (AE-ILD). This study aimed to clarify the causes of AE-ILD, determine the efficacy of corticosteroids for treating AE-ILD, and detect differences in the mortality rate among subgroups of ILD. This was an observational retrospective single-center study. Patients with ILD who presented to the emergency department with
    Document: Interstitial lung disease (ILD), particularly idiopathic pulmonary fibrosis (IPF), has a poor prognosis. Corticosteroids are widely used in the treatment of acute exacerbation of ILD (AE-ILD). This study aimed to clarify the causes of AE-ILD, determine the efficacy of corticosteroids for treating AE-ILD, and detect differences in the mortality rate among subgroups of ILD. This was an observational retrospective single-center study. Patients with ILD who presented to the emergency department with acute respiratory symptoms from January 1, 2016, to December 31, 2018, were included. Patients with AE-ILD were classified into two groups depending on the prednisolone dose: low dose (0 to 1.0 mg/kg) or high dose (> 1.0 mg/kg). Mortality rates between patients with and without IPF were compared. This study included 182 patients with AE-ILD, including IPF (n = 117) and non-IPF (n = 65). Multivariate Cox regression analysis showed that corticosteroid dose (HR: 0.221, CI: 0.102–0.408, P < 0.001), initial P/F ratio (HR:0.995, CI:0.992–0.999, P = 0.006), and mechanical ventilation within 3 days of hospitalization (HR:4.205, CI:2.059–8.589, P < 0.001) were independent risk factors for mortality in patients with AE-ILD. This study showed that outcomes improve with higher doses of corticosteroids (> 1 mg/kg prednisolone) in patients with AE-non-IPF-ILD. However, this was not the case in patients with AE-IPF.

    Search related documents:
    Co phrase search for related documents
    • acute exacerbation and low baseline: 1
    • acute exacerbation and low quality: 1, 2, 3
    • acute exacerbation and low quality evidence: 1, 2
    • acute exacerbation and lung cancer: 1, 2, 3, 4, 5, 6
    • acute exacerbation and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and logistic regression model: 1
    • acute lung injury and low quality: 1, 2, 3
    • acute lung injury and low quality evidence: 1, 2
    • acute lung injury and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute lung injury and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory decline and low oxygenation: 1
    • acute respiratory decline and lung disease: 1
    • acute respiratory distress syndrome and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute respiratory distress syndrome and low baseline: 1, 2, 3
    • acute respiratory distress syndrome and low oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and low quality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory distress syndrome and low quality evidence: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory distress syndrome and low survival rate: 1
    • acute respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25